Kampen; Gita Camilla Tejlgaard

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kampen; Gita Camilla Tejlgaard.The latest application filed is for "pharmaceutical use of substituted amides".

Company Profile

0.7.20

Kampen; Gita Camilla Tejlgaard - Naerum DK
Kampen; Gita Camilla Tejlgaard - N.ae butted.rum DK
Kampen; Gita Camilla Tejlgaard - N.ae butted.run DK
Kampen; Gita, Camilla Tejlgaard - Kampen DK

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Indole- and benzimidazole amides as hydroxysteroid dehydrogenase inhibitors Grant 8,153,798 - Kilburn , et al. April 10, 2	2012-04-10
11.beta.-hydroxysteroid dehydrogenase type 1 active spiro compounds Grant 8,138,342 - Kilburn , et al. March 20, 2	2012-03-20
Pharmaceutical Use Of Substituted Amides App 20110312949 - Kilburn; John Paul ; et al.	2011-12-22
Pharmaceutical use of substituted amides Grant 8,053,431 - Kilburn , et al. November 8, 2	2011-11-08
Pharmaceutical Use Of Fused 1,2,4-triazoles App 20100197658 - Andersen; Henrik Sune ; et al.	2010-08-05
Pharmaceutical use of fused 1,2,4-triazoles Grant 7,723,323 - Andersen , et al. May 25, 2	2010-05-25
11Beta-Hydroxysteroid Dehydrogenase Type 1 Active Compounds App 20100120743 - Gundertofte; Anette ; et al.	2010-05-13
11.beta.-hydroxysteroid dehydrogenase type 1 active compounds Grant 7,700,583 - Gundertofte , et al. April 20, 2	2010-04-20
Indole- And Benzimidazole Amides As Hydroxysteroid Dehydrogenase Inhibitors App 20100076041 - Kilburn; John Paul ; et al.	2010-03-25
Pharmaceutical Use Of Substituted Piperidine Carboxamides App 20090306048 - Kilburn; John Paul ; et al.	2009-12-10
Amide Derivatives and Pharmaceutical Use Thereof App 20090264414 - Andersen; Henrik Sune ; et al.	2009-10-22
Combination Therapy Using An 11beta-Hydroxysteroid Dehydrogenase Type 1 Inhibitor And A Glucocorticoid Receptor Agonist To Minimize The Side Effects Associated With Glucocorticoid Receptor Agonist Therapy App 20090264412 - Kampen; Gita Camilla Tejlgaard ; et al.	2009-10-22
Combination Therapy Using an 11Beta-Hydroxysteroid Dehydrogenase Type 1 Inhibitor and an Antihypertensive Agent for the Treatment of Metabolic Syndrome and Related Diseases and Disorders App 20090137574 - Kampen; Gita Camilla Tejlgaard ; et al.	2009-05-28
Pharmaceutical Use Of Substituted Amides App 20090124598 - Andersen; Henrik Sune ; et al.	2009-05-14
Pharmaceutical Use Of Substituted Amides App 20090118259 - Kilburn; John Paul ; et al.	2009-05-07
11beta-hydroxysteroid dehydrogenase type 1 active spiro compounds App 20090105289 - Kilburn; John Paul ; et al.	2009-04-23
Combination therapy using an 11.beta.-hydroxysteroid dehydrogenase type 1 inhibitor and an antihypertensive agent for the treatment of metabolic syndrome and related diseases and disorders Grant 7,501,405 - Kampen , et al. March 10, 2	2009-03-10
Pharmaceutical Use of Fused 1,2,4-Triazoles App 20080153807 - Andersen; Henrik Sune ; et al.	2008-06-26
Pharmaceutical use of substituted amides App 20080108598 - Andersen; Henrik Sune ; et al.	2008-05-08
Pharmaceutical use of fused 1,2,4-triazoles Grant 7,358,238 - Andersen , et al. April 15, 2	2008-04-15
Pharmaceutical use of substituted pyrazolo[1,5-a]pyrimidines App 20070270408 - Andersen; Henrik Sune ; et al.	2007-11-22
Combination therapy using an 11beta-hydroxysteroid dehydrogenase type 1 inhibitor and an antihypertensive agent for the treatment of metabolic syndrome and related diseases and disorders App 20060111348 - Kampen; Gita Camilla Tejlgaard ; et al.	2006-05-25
Pharmaceutical use of substituted amides App 20060111366 - Andersen; Henrik Sune ; et al.	2006-05-25
Pharmaceutical use of fused 1,2,4-triazoles App 20060106008 - Andersen; Henrik Sune ; et al.	2006-05-18
Pharmaceutical use of substituted 1,2,4-triazoles App 20060100235 - Andersen; Henrik Sune ; et al.	2006-05-11
Combination therapy using an 11beta-hydroxysteroid dehydrogenase type 1 inhibitor and a glucocorticoid receptor agonist to minimize the side effects associated with glucocorticoid receptor agonist therapy App 20060094699 - Kampen; Gita Camilla Tejlgaard ; et al.	2006-05-04
11beta-hydroxysteroid dehydrogenase type 1 active compounds App 20060089349 - Gundertofte; Anette ; et al.	2006-04-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.